EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet

Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-023-02889-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Seung-Hyun Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sunchon National University, 255 Jungang-Ro, Jeollanam-Do, Suncheon-Si, 57922, Republic of Korea. Hauptthemen laut MEDLINE: Models, Biological, Tablets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Research Foundation of Korea, Handok Jeseok Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levodropropizine, a nonopioid antitussive agent, is being increasingly used in clinical practice with the development of several formulations for symptomatic relief of acute and chronic bronchitis. However, scientific and quantitative population pharmacokinetic analyses of levodropropizine are lacking. Moreover, no integrated quantitative comparison has been performed between formulations. This study quantitatively evaluated and predicted pharmacokinetic properties of formulations through population pharmacokinetic model-based comparisons of commercially available formulations. Plasma concentration profile results from bioequivalence studies of 60-mg immediate release (IR) levodropropizine tablets in 40 healthy Korean males were used as population pharmacokinetic modeling data. For interindividual variability in levodropropizine pharmacokinetics, body surface area was identified as an effective covariate that was positively correlated with peripheral compartment distribution volume. Population pharmacokinetic model for IR tablets well-described the levodropropizine syrup and capsule datasets, suggesting no significant differences in pharmacokinetics among IR tablets, syrups, and capsules of levodropropizine. In contrast, pharmacokinetic profiles differed between 90-mg controlled release (CR) and IR levodropropizine tablets; however, separate parameter estimation was possible by applying the same model structure. In terms of pharmacokinetics, twice-daily regimen of 90-mg CR tablets was equivalent to thrice-daily regimen of 60-mg IR tablets. However, at steady-state, interindividual plasma concentration variability within population was reduced by approximately 36.71-83.18%. For levodropropizine CR tablets, a high-fat diet significantly delayed gastrointestinal absorption but maintained overall plasma exposure equivalent. This study provides useful quantitative judgment data for precision medicine of levodropropizine and can be helpful in predicting the pharmacokinetics of levodropropizine based on commercialized formulation switching.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalTabletsMaleHumansAdultYoung AdultTherapeutic EquivalencyAntitussive AgentsDelayed-Action PreparationsDietCross-Over StudiesFood-Drug InteractionsCapsulesPropylene Glycols

Stichwörter der Autor:innen

Body surface areaControlled release tabletHigh-fat dietImmediate release tabletLevodropropizinePopulation pharmacokinetic modeling

Substanzen

TabletsAntitussive AgentsDelayed-Action PreparationsCapsulesPropylene Glycolsdipropizine

Autor:innen und Institutionen

  • College of Pharmacy, Sunchon National University, 255 Jungang-Ro, Jeollanam-Do, Suncheon-Si, 57922, Republic of Korea.
  • College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon-Si, 57922, Republic of Korea.
  • College of Pharmacy, Chonnam National University, 77 Yongbong-Ro, Buk-Gu, Gwangju, 61186, Republic of Korea. leeyb@chonnam.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Handok Jeseok Foundation

Zitieren

APA

Jeong, S. H., Jang, J. H., & Lee, Y. B. (2024). Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02889-5

Vancouver

Jeong SH, Jang JH, Lee YB. Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-023-02889-5

BibTeX
@article{Jeong2024,
  author = {Jeong, Seung-Hyun and Jang, Ji-Hun and Lee, Yong-Bok},
  title = {Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-023-02889-5}
}
Kostenlos starten →